SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001578563-24-000013
Filing Date
2024-01-12
Accepted
2024-01-12 16:39:42
Documents
2
Period of Report
2024-01-10

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2112
2 POA poarclaypoole.txt EX-24 3613
  Complete submission text file 0001578563-24-000013.txt   7210
Mailing Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703 (919) 474-6700
Bioventus Inc. (Issuer) CIK: 0001665988 (see all company filings)

IRS No.: 810980861 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address C/O BIOVENTUS INC. 4721 EMPEROR BLVD, SUITE 100 DURHAM NC 27703
Business Address
Claypoole Robert E (Reporting) CIK: 0002005474 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37844 | Film No.: 24532514